Hui-Kuan Lin
Hui-Kuan Lin is a prominent scientist known for his contributions to the field of cancer research. He is currently a professor at the MD Anderson Cancer Center, where he focuses on understanding the molecular mechanisms underlying cancer progression and metastasis.
Early Life and Education[edit | edit source]
Hui-Kuan Lin was born in Taiwan. He completed his undergraduate studies in Biology at the National Taiwan University. He then pursued a Ph.D. in Molecular Biology at the University of Texas Southwestern Medical Center.
Career[edit | edit source]
After completing his Ph.D., Lin joined the MD Anderson Cancer Center as a postdoctoral fellow. His research primarily focuses on the role of ubiquitin-proteasome system in cancer. He has published numerous papers in high-impact scientific journals and has been recognized with several awards for his groundbreaking work.
Research Contributions[edit | edit source]
Lin's research has significantly advanced the understanding of how the ubiquitin-proteasome system regulates various cellular processes, including cell cycle, apoptosis, and DNA repair. His work has identified several key proteins involved in these processes, providing potential targets for new cancer therapies.
Awards and Honors[edit | edit source]
- American Association for Cancer Research (AACR) Award for Outstanding Achievement in Cancer Research
- National Institutes of Health (NIH) R01 Grant
- MD Anderson Cancer Center Faculty Achievement Award
Personal Life[edit | edit source]
Hui-Kuan Lin is married and has two children. He enjoys hiking and photography in his free time.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Template:MD Anderson Cancer Center
 | This biographical article about a scientist is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
